Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ATROPINE SULFATE IN

Closed
SPE2DP-26-T-3572Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

ATROPINE SULFATE INJECTION, USP, designated by NSN 6505014745440, is being procured under solicitation SPE2DP-26-T-3572 for delivery to U.S. military vessels and facilities, with a requirement for 4 packaging groups totaling 40 units, each containing 10 vials of 0.4 mg per mL in 20 mL multidose vials. The product must have a minimum shelf life of 24 months from manufacture, with no less than 21 months remaining at the time of government receipt, and is subject to FDA regulation. All packaging and labeling must strictly conform to Medical Marking Standard No. 1, which overrides MIL-STD-129, requiring clear inclusion of NSN, manufacturer and Cage code, date of manufacture, expiration or retest date, contract number, and lot number. Each unit must be sealed in a protective container, with outer shipping containers suitable for commercial carrier transport, including export configurations when necessary. Palletization must adhere to DLA Packaging Requirements RP001, and hazardous material handling must comply with TQ requirement IP025 or ASTM D3951 if non-hazardous, with all DLA Master List of Technical and Quality Requirements taking precedence over general standards. Delivery is FOB destination within 20 days of order placement, with no quantity variance permitted, and inspection and acceptance occur at the final delivery point. The contract mandates use of Wide Area WorkFlow for electronic invoicing and receiving reports, with payment processing requiring accurate System for Award Management registration and compliance with all FAR and DFARS clauses including whistleblower protections, cybersecurity safeguarding, employment eligibility verification, and combating trafficking. All offerors must affirm their SAM status, small business eligibility, and compliance with the Berry Amendment, with foreign-sourced content requiring explicit disclosure. The contract includes multiple FAR clauses with deviation 2026-00038 applied across several provisions to streamline procurement and enhance oversight. The material must be shipped via traceable means, avoiding parcel post, to designated military addresses such as USS CARL VINSON CVN 70. Manufacturers must be qualified, with existing approved sources including HIKMA PHARMACEUTICALS USA INC. and FRESENIUS KABI, LLC, and the solicitation may result in automated award if competitive pricing and compliance thresholds are met.

General Info

Procurement of 0.4 mg/ml Atropine Sulfate Injection, 20 ml vials, strict packaging, delivery, and inspection.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3572 Medical Supply Chain

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Solicitation

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
ATROPINE SULFATE IN
ATROPINE SULFATE INJECTION, USP<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
0.4 MG PER ML, 20 ML MDV, 10S<(>,<)>
.
.
UNIT OF ISSUE PACKAGE 10'S
.
SHALL HAVE A SHELF LIFE OF 24 MONTHS.
NOT LESS THAN 21 MONTHS SHALL HAVE ELAPSED FROM
DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE
GOVERNMENT.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
1 PG = 10 EA
LABELS SHALL INCLUDE:
NSN
MANUFACTURER AND CAGE
DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE
CONTRACT NUMBER/LOT NUMBER
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . NSN 6505014745440 1/27/16
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
SPE2DP-26-T-3572
SECTION B
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
HIKMA PHARMACEUTICALS USA INC. 32655 P/N NDC00641-6006-10 FRESENIUS KABI, LLC 57KZ6 P/N NDC63323-0580-20
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016955943 0001 PG 3.000
NSN/MATERIAL:6505014745440
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
SPE2DP-26-T-3572
SECTION B
PR: 7016955943 PRLI: 0001 CONT’D
R20993
USS CARL VINSON CVN 70
UNIT 100111 BOX 1
FPO AP 96629
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R20993
USS CARL VINSON CVN 70
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R209935177P105
RDD: 777
PROJ: EK5 TP 2
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A4A DIST: 9B ADV: 2A FC: L7
Need Ship Date:00/00/0000 Original Required Delivery Date:09/18/2025
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7016941259 0001 PG 1.000
NSN/MATERIAL:6505014745440
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-474-5440 Quantity: 3 PG Purchase Request: 7016941259QTY: 1 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS